TRABECTEDIN Side Effects

6938431-8 | Alanine Aminotransferase Abnormal, Blood Alkaline Phosphatase Abnormal, Blood Bilirubin Abnormal, Dehydration, Hyperglycaemia, Hypoalbuminaemia, Hypotension, Neutropenic Sepsis
on Aug 17, 2010 Female patient from SPAIN , weighting 148.8 lb, was diagnosed with ovarian cancer, depression (What is depression?) and was treated with Trabectedin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase abnormal, blood alkaline phosphatase abnormal, blood bilirubin abnormal, dehydration, hyperglycaemia, hypoalbuminaemia, hypotension, neutropenic sepsis. Trabectedin dosage: . During the same period patient was treated with DOXIL (View Doxil Review and Doxil Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CHLORHEXIDINE GLUCONATE (View Chlorhexidine Gluconate Review and Chlorhexidine Gluconate Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ), BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ). Patient was hospitalized.

6938163-6 | Arterial Thrombosis Limb, Cardiac Arrest, Dehydration, Electromechanical Dissociation, Hypoxia, Pancytopenia, Peripheral Ischaemia, Renal Failure Acute, Respiratory Failure
Patient was taking Trabectedin (View Usage). Patient had the following side effects: arterial thrombosis limb, cardiac arrest (What is cardiac arrest?), dehydration, electromechanical dissociation, hypoxia, pancytopenia, peripheral ischaemia, renal failure acute, respiratory failure on Aug 17, 2010 from UNITED STATES Additional patient health information: Female patient , weighting 138.0 lb, was diagnosed with ovarian cancer and. Trabectedin dosage: . During the same period patient was treated with DOXIL (View Doxil Review and Doxil Label ), PROTONIX (View Protonix Review and Protonix Label ), AMBIEN (View Ambien Review and Ambien Label ), MARINOL (View Marinol Review and Marinol Label ). Patient was hospitalized.

6922588-9 | Leukopenia, Neutropenia, Pyrexia, Thrombocytopenia, Transaminases Increased
Adverse event was reported on Jul 30, 2010 by a Female patient taking Trabectedin (View Usage) (Dosage: ) was diagnosed with ovarian cancer and. Location: GERMANY , 70 years of age, weighting 132.3 lb, After Trabectedin was administered, patient had the following side effects: leukopenia, neutropenia, pyrexia, thrombocytopenia, transaminases increased. During the same period patient was treated with CAELYX (View Caelyx Review and Caelyx Label ), ZOFRAN (View Zofran Review and Zofran Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6916796-0 | Leukopenia, Neutropenia, Thrombocytopenia
on Jul 30, 2010 Female patient from GERMANY , 70 years of age, weighting 132.3 lb, was diagnosed with ovarian cancer and was treated with Trabectedin (View Usage). Patient experienced the following unwanted or unexpected effects: leukopenia, neutropenia, thrombocytopenia. Trabectedin dosage: . During the same period patient was treated with CAELYX (View Caelyx Review and Caelyx Label ), ZOFRAN (View Zofran Review and Zofran Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.


6879757-6 | Leukopenia, Neutropenia, Thrombocytopenia
on Jul 19, 2010 Female patient from GERMANY , 70 years of age, weighting 132.3 lb, was diagnosed with ovarian cancer and was treated with Trabectedin (View Usage). Patient had the following side effects: leukopenia, neutropenia, thrombocytopenia. Trabectedin dosage: . During the same period patient was treated with CAELYX (View Caelyx Review and Caelyx Label ), ZOFRAN (View Zofran Review and Zofran Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6847412-4 | Neutropenic Sepsis, Renal Failure Acute
Patient was taking Trabectedin (View Usage). After Trabectedin was administered, patient had the following side effects: neutropenic sepsis, renal failure acute on Jul 06, 2010 from UNITED KINGDOM Additional patient health information: Female patient , weighting 148.8 lb, was diagnosed with ovarian cancer, depression (What is depression?) and. Trabectedin dosage: . During the same period patient was treated with DOXIL (View Doxil Review and Doxil Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CHLORHEXIDINE (View Chlorhexidine Review and Chlorhexidine Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ), BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ). Patient was hospitalized.

6839367-3 | Alanine Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Blood Bilirubin Increased, Dehydration, Hyperglycaemia, Hypoalbuminaemia, Hypoglycaemia, Neutropenic Sepsis, Oral Pain
Adverse event was reported on Jul 06, 2010 by a Female patient taking Trabectedin (View Usage) (Dosage: ) was diagnosed with ovarian cancer, depression (What is depression?) and. Location: UNITED KINGDOM , weighting 148.8 lb, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, dehydration, hyperglycaemia, hypoalbuminaemia, hypoglycaemia, neutropenic sepsis, oral pain. During the same period patient was treated with DOXIL (View Doxil Review and Doxil Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CHLORHEXIDINE (View Chlorhexidine Review and Chlorhexidine Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ), BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ). Patient was hospitalized.

6835647-6 | Neutropenic Sepsis, Renal Failure Acute
on Jul 06, 2010 Female patient from UNITED KINGDOM , weighting 148.8 lb, was diagnosed with ovarian cancer, depression (What is depression?) and was treated with Trabectedin (View Usage). Patient had the following side effects: neutropenic sepsis, renal failure acute. Trabectedin dosage: . During the same period patient was treated with DOXIL (View Doxil Review and Doxil Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), CHLORHEXIDINE (View Chlorhexidine Review and Chlorhexidine Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ), BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ). Patient was hospitalized.

6816474-2 | Acute Myocardial Infarction, Cardiac Failure
on Jun 21, 2010 Male patient from GERMANY , weighting 205.0 lb, was diagnosed with sarcoma, platelet aggregation inhibition, hypertension, hypercholesterolaemia and was treated with Trabectedin (View Usage). After Trabectedin was administered, patient had the following side effects: acute myocardial infarction, cardiac failure. Trabectedin dosage: 3mg, Cycle 1. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized and became disabled.

6803020-2 | Acute Myocardial Infarction, Anaemia, Cardiac Failure, Circulatory Collapse, Coronary Artery Occlusion, Hepatic Angiosarcoma, Metastases To Lung, Mitral Valve Incompetence, Oedema
Patient was taking Trabectedin (View Usage). Patient experienced the following unwanted or unexpected effects: acute myocardial infarction, anaemia, cardiac failure, circulatory collapse, coronary artery occlusion, hepatic angiosarcoma, metastases to lung, mitral valve incompetence, oedema on Jun 21, 2010 from GERMANY Additional patient health information: Male patient , weighting 205.0 lb, was diagnosed with sarcoma, platelet aggregation inhibition, hypertension, hypercholesterolaemia and. Trabectedin dosage: 3mg, Cycle 1. During the same period patient was treated with DOXORUBICIN (View Doxorubicin Review and Doxorubicin Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), DIOVAN HCT (View Diovan Hct Review and Diovan Hct Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized and became disabled.

6800990-3 | Neutropenic Sepsis, Renal Failure Acute
Adverse event was reported on Jun 22, 2010 by a Female patient taking Trabectedin (View Usage) (Dosage: ) was diagnosed with ovarian cancer, depression (What is depression?) and. Location: UNITED KINGDOM , weighting 148.8 lb, Patient had the following side effects: neutropenic sepsis, renal failure acute. During the same period patient was treated with DOXIL (View Doxil Review and Doxil Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), CHLORHEXIDINE (View Chlorhexidine Review and Chlorhexidine Label ), NORMAL SALINE (View Normal Saline Review and Normal Saline Label ), BLOOD TRANSFUSION (View Blood Transfusion Review and Blood Transfusion Label ). Patient was hospitalized.

6636176-5 | Cardiac Failure
on Mar 08, 2010 Male patient from GERMANY , weighting 205.0 lb, was diagnosed with sarcoma, platelet aggregation inhibition, hypertension, hypercholesterolaemia and was treated with Trabectedin (View Usage). After Trabectedin was administered, patient had the following side effects: cardiac failure. Trabectedin dosage: 3mg, Cycle 1. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), ACETYLSALICYLIC ACID SRT (View Acetylsalicylic Acid Srt Review and Acetylsalicylic Acid Srt Label ), CODIOVAN (View Codiovan Review and Codiovan Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized and became disabled.

5471109-9 | Nausea, Pyrexia, Syncope Vasovagal
on Sep 18, 2007 Female patient from CANADA , weighting 151.0 lb, was diagnosed with ovarian cancer, constipation prophylaxis, pyrexia and was treated with Trabectedin (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), pyrexia, syncope vasovagal. Trabectedin dosage: Cycle 5. During the same period patient was treated with DOXORUBICIN HCL (Cycle 5) (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), NEUPOGENE (View Neupogene Review and Neupogene Label ), ATIVAN (View Ativan Review and Ativan Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ). Patient was hospitalized.

5444486-2 | Nausea, Pyrexia, Syncope Vasovagal
Patient was taking Trabectedin (View Usage). Patient had the following side effects: nausea (What is nausea?), pyrexia, syncope vasovagal on Aug 29, 2007 from CANADA Additional patient health information: Female patient , weighting 162.9 lb, was diagnosed with ovarian cancer and. Trabectedin dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

5432970-7 | Infection, Nausea, Pyrexia, Syncope Vasovagal
Adverse event was reported on Aug 21, 2007 by a Female patient taking Trabectedin (View Usage) (Dosage: ) was diagnosed with ovarian cancer and. Location: CANADA , weighting 162.9 lb, After Trabectedin was administered, patient had the following side effects: infection (What is infection?), nausea (What is nausea?), pyrexia, syncope vasovagal. During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.

5422114-X | Nausea, Pyrexia
on Aug 15, 2007 Female patient from CANADA , weighting 162.9 lb, was diagnosed with ovarian cancer and was treated with Trabectedin (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?), pyrexia. Trabectedin dosage: . During the same period patient was treated with DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ). Patient was hospitalized.